304 related articles for article (PubMed ID: 8397447)
21. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
Mehtani VG; Joshi K; Mehrotra GC
Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
[No Abstract] [Full Text] [Related]
22. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
Contesso G
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
[No Abstract] [Full Text] [Related]
23. Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S; Rosa M
Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
[TBL] [Abstract][Full Text] [Related]
24. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
25. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
Bässler R; Werner J
Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
[No Abstract] [Full Text] [Related]
26. [Histologic classification of breast cancer and its precancerous stages].
Nizze H
Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
[TBL] [Abstract][Full Text] [Related]
27. In situ carcinomas of the female breast. Diagnostic and therapeutic aspects with special reference to histological growth patterns. Clinical review.
Blichert-Toft M; Andersen J; Dyreborg U
Acta Chir Scand; 1990 Feb; 156(2):113-9. PubMed ID: 2158737
[TBL] [Abstract][Full Text] [Related]
28. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
Sahoo S; Recant WM
Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
[TBL] [Abstract][Full Text] [Related]
29. [Value of cytology for diagnosis of breast cancer].
Tessmann D; Pommerenke F
Z Arztl Fortbild (Jena); 1990; 84(14):719-21. PubMed ID: 2176017
[No Abstract] [Full Text] [Related]
30. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
31. [A new computerized semi-automatic approach to cytomorphometric diagnosis: individualization of a discriminating function and its application in breast pathology].
Ferrario VF; Fiaccavento S; Vizzotto L; Molinari Tosatti MP; Miani A
Pathologica; 1984; 76(1043):359-67. PubMed ID: 6093028
[No Abstract] [Full Text] [Related]
32. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
Walther B; Rutter G; Stegner HE; Böcker W
Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
[No Abstract] [Full Text] [Related]
33. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
34. In situ proliferative epithelial lesions of the breast.
Kamel OW; Kempson RL; Hendrickson MR
Pathology (Phila); 1992; 1(1):65-102. PubMed ID: 9420916
[TBL] [Abstract][Full Text] [Related]
35. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
36. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
Shirley SE
West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.
Page DL; Dupont WD; Rogers LW
Cancer Detect Prev; 1986; 9(5-6):441-8. PubMed ID: 3779706
[TBL] [Abstract][Full Text] [Related]
38. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
Kluttig A; Trocchi P; Heinig A; Holzhausen HJ; Taege C; Hauptmann S; Boecker W; Decker T; Loening T; Schmidt-Pokrzywniak A; Thomssen C; Lantzsch T; Buchmann J; Stang A
BMC Cancer; 2007 Jun; 7():100. PubMed ID: 17570833
[TBL] [Abstract][Full Text] [Related]
39. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
40. New aspects in the histological diagnosis of breast carcinoma.
Shousha S
Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
